PATH: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
PATH: Announcement of Keio University Professor Okano Hideyuki's appointment as an RMDC advisor
PATH: Notice Concerning Re-Change in Use of Funds for the 12th Stock Acquisition Rights
PATH: Change Report
PATH: Correction Report (Mass Ownership Report/Change Report)
PATH: Correction Report (Mass Ownership Report/Change Report)
PATH: Change Report
PATH: Correction Report (Mass Ownership Report/Change Report)
Pass: Corrected Report (Mass Ownership Report/Change Report)
PATH: Change Report
Pass: Mass Ownership Report
Pass: Confirmation
Pass: Quarterly Report - 34th Quarter (2023/10/01 to 2023/12/31)
PATH: Summary of Financial Results for the 3rd Quarter Ending March 31, 2024 [Japanese GAAP] (Consolidated)
PATH: Notice regarding revisions to earnings forecasts
PATH: Notice regarding changes in the use of funds under the 12th Stock Acquisition Rights
PATH: Change Report
PATH: “Fucoxanthin” Hokkaido Health Sciences University Research Results Part 2! A paper on anticancer effects on model mice has been published!
PATH: Notice Concerning Acquisition of Fixed Assets (Buildings, etc.) by Consolidated Subsidiaries
PATH: Quarterly Report - 34th Second Quarter (2023/07/01 - 2023/09/30)
No Data